GO
Live price temporarily unavailable.
Price history
Gossamer Bio Inc (GOSS) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: February 8, 2019 · $16.00 offering · NASDAQ · View IPO details →
Recent News (2)
-
Gossamer (GOSS) Announced Up to $250M of Financing, but Only $25M is Expected Upfront. Is the Runway Secure?
Gossamer (GOSS) Announced Up to $250M of Financing, but Only $25M is Expected Upfront. Is the Runway Secure?
-
Gossamer Bio announces $250m in funding to advance seralutinib
Gossamer Bio announces $250m in funding to advance seralutinib
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International